Penumbra
Alameda, California, United States, North America
Overview
Penumbra designs, develops, manufactures and markets medical devices for interventional therapies addressing neurovascular and vascular conditions. The company’s product range includes mechanical thrombectomy systems, peripheral thrombectomy tools, access catheters, embolization devices and neurosurgical tools used by healthcare providers and hospitals globally. Its offerings support procedures such as clot removal in acute ischemic stroke, vascular embolization and other minimally invasive interventions. Penumbra sells through direct sales teams and distributor networks, and provides clinical support to practitioners integrating its technologies into treatment workflows.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 8
Sector focus
- Biotechnology
- Developer Platform
- Medical Device
Investment portfolio
- Magnendo
Led · Series A · Jul 2026
Magnendo has spent roughly two years building medical technologies focused on improving endovascular access for stroke intervention. The company emphasizes collaboration with clinical partners and a dedicated internal team as central to its progress. With the newly closed $18M Series A led by Penumbra, Inc., Magnendo intends to enter a phase of growth to advance its mission of making life-saving endovascular procedures faster, safer and more accessible. The announcement frames the financing as supporting continued product and clinical development and scaling, though no specific operating metrics or revenue figures were disclosed. The company highlighted gratitude to its team, collaborators, and investors as it moves forward.